WAREHAM, MA--(Marketwire - July 17, 2008) - Synomics Pharmaceutical Services, LLC, a leader in bioanalytical, stability and analytical testing services for the pharmaceutical industry, announced today that the U.S. Food and Drug Administration (FDA) has completed an inspection of its facilities and operations in Wareham, Massachusetts. The inspection included both PAI and general regulatory compliance, as Synomics Pharma had been named in three NDAs. No form 483 was issued.
